MAAT INDEX

CLAIM #69799 · EMR (EMR) · 2026Q3 earnings call · Nov 2, 2026 · due Dec 31, 2027

At this point, I continue to be relatively robust on semiconductors through 2027.

Lal Karsanbhai · CEO

PENDING
graded after results covering Dec 31, 2027 are reported

In context

Lal Karsanbhai (President and Chief Executive Officer): I'll follow up on the semiconductor question. We're not guiding into 2027 today, but you can read into the tremendous order momentum we have in the semiconductor business within Test & Measurement. There is differentiation in growth by application. The validation and production side, where we largely play, has a different dynamic on growth and the cycle as well. At this point, I continue to be relatively robust on semiconductors through 2027.

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2026Q3 earnings call.